Abstract
AbstractThe concept of agonist-independent signalling that can be attenuated by inverse agonists is a fundamental element of the cubic ternary complex model of G protein-coupled receptor (GPCR) activation. This model shows how a GPCR can exist in two conformational states in the absence of ligands; an inactive R state and an active R* state that differ in their affinities for agonists, inverse agonists, and G-protein alpha subunits. The proportion of R* receptors that exist in the absence of agonists determines the level of constitutive receptor activity. In this study we demonstrate that mechanical stimulation can induce β2-adrenoceptor agonist-independent Gs-mediated cAMP signalling that is sensitive to inhibition by inverse agonists such as ICI-118551 and propranolol. The size of the mechano-sensitive response is dependent on the cell surface receptor expression level in HEK293G cells, is still observed in a ligand-binding deficient D113A mutant β2-adrenoceptor and can be attenuated by site-directed mutagenesis of the extracellular N-glycosylation sites on the N-terminus and second extracellular loop of the β2-adrenoceptor. Similar mechano-sensitive agonist-independent responses are observed in HEK293G cells overexpressing the A2A-adenosine receptor. These data provide new insights into how agonist-independent constitutive receptor activity can be enhanced by mechanical stimulation and regulated by inverse agonists.
Funder
RCUK | Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Billington, C. K., Ojo, O. O., Penn, R. B. & Ito, S. cAMP regulation of airway smooth muscle function. Pulm. Pharm. Ther. 26, 112–120 (2013).
2. Feldman, R. D. & Gros, R. Impaired vasodilator function in hypertension: the role of alterations in receptor-G protein coupling. Trends Cardiovasc. Med. 8, 297–305 (1998).
3. Pérez-Schindler, J., Philp, A. & Hernandez-Cascales, J. Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function. Eur. J. Pharm. 698, 39–47 (2013).
4. Tanaka, Y., Horinouchi, T. & Koike, K. New insights into beta-adrenoceptors in smooth muscle: distribution of receptor subtypes and molecular mechanisms triggering muscle relaxation. Clin. Exp. Pharm. Physiol. 32, 503–514 (2005).
5. Yu, W. et al. Norepinephrine stimulation downregulates the β2 -adrenergic receptor-nitric oxide pathway in human pulmonary artery endothelial cells. J. Cell Physiol. 234, 842–1850 (2019).